$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra

$zvra Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000143774922012182 Filed on May 12, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$3.965M	$12.12M
YoY Change	-67.28%	480.04%
Cost Of Revenue	$8.000K
YoY Change
Gross Profit	$3.957M
YoY Change
Gross Profit Margin	99.8%
Selling, General & Admin	$2.734M	$1.890M
YoY Change	44.66%	-29.21%
% of Gross Profit	69.09%
Research & Development	$3.082M	$2.265M
YoY Change	36.07%	6.54%
% of Gross Profit	77.89%
Depreciation & Amortization	$65.00K	$64.00K
YoY Change	1.56%	-11.11%
% of Gross Profit	1.64%
Operating Expenses	$3.082M	$2.265M
YoY Change	36.07%	6.54%
Operating Profit	-$1.859M	$6.960M
YoY Change	-126.71%	-284.37%
Interest Expense	$5.000K	$199.0K
YoY Change	-97.49%	-84.21%
% of Operating Profit		2.86%
Other Income/Expense, Net	-$9.000K	-$17.26M
YoY Change	-99.95%	771.96%
Pretax Income	-$1.868M	-$10.30M
YoY Change	-81.86%	78.94%
Income Tax	-$4.000K	$0.00
% Of Pretax Income
Net Earnings	-$1.864M	-$10.30M
YoY Change	-81.9%	78.94%
Net Earnings / Revenue	-47.01%	-84.97%
Basic Earnings Per Share	-$0.05	-$2.49
Diluted Earnings Per Share	-$54.02K	-$2.49
COMMON SHARES
Basic Shares Outstanding	34.51M	19.15M
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$101.6M	$75.90M
YoY Change	33.83%	3062.5%
Cash & Equivalents	$100.2M	$75.92M
Short-Term Investments	$1.338M
Other Short-Term Assets	$880.0K	$500.0K
YoY Change	76.0%	-44.44%
Inventory
Prepaid Expenses
Receivables	$3.320M	$11.30M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$105.8M	$87.73M
YoY Change	20.58%	1491.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$835.0K	$975.0K
YoY Change	-14.36%	-19.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$17.56M
YoY Change
Other Assets	$437.0K	$437.0K
YoY Change	0.0%	-17.08%
Total Long-Term Assets	$19.93M	$2.706M
YoY Change	636.36%	-19.8%
TOTAL ASSETS
Total Short-Term Assets	$105.8M	$87.73M
Total Long-Term Assets	$19.93M	$2.706M
Total Assets	$125.7M	$90.44M
YoY Change	39.0%	917.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.582M	$2.900M
YoY Change	-10.97%	-54.69%
Accrued Expenses	$356.0K	$300.0K
YoY Change	18.67%	0.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$7.000K	$800.0K
YoY Change	-99.13%	-98.84%
Total Short-Term Liabilities	$2.945M	$4.238M
YoY Change	-30.51%	-94.39%
LONG-TERM LIABILITIES
Long-Term Debt	$4.000K	$100.0K
YoY Change	-96.0%	0.0%
Other Long-Term Liabilities	$29.00K	$14.00K
YoY Change	107.14%	-88.43%
Total Long-Term Liabilities	$29.00K	$14.00K
YoY Change	107.14%	-88.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.945M	$4.238M
Total Long-Term Liabilities	$29.00K	$14.00K
Total Liabilities	$4.207M	$6.184M
YoY Change	-31.97%	-92.03%
SHAREHOLDERS EQUITY
Retained Earnings	-$268.9M	-$268.8M
YoY Change	0.05%	6.88%
Common Stock	$397.9M	$353.0M
YoY Change	12.72%	93.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$7.536M
YoY Change
Treasury Stock Shares
Shareholders Equity	$121.5M	$84.25M
YoY Change
Total Liabilities & Shareholders Equity	$125.7M	$90.44M
YoY Change	39.0%	917.84%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$1.864M	-$10.30M
YoY Change	-81.9%	78.94%
Depreciation, Depletion And Amortization	$65.00K	$64.00K
YoY Change	1.56%	-11.11%
Cash From Operating Activities	-$3.485M	-$2.586M
YoY Change	34.76%	27.89%
INVESTING ACTIVITIES
Capital Expenditures	$16.00K	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$3.832M
YoY Change
Cash From Investing Activities	-$3.848M	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$4.723M	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$4.801M	$74.29M
YoY Change	-106.46%	7183.33%
NET CHANGE
Cash From Operating Activities	-$3.485M	-$2.586M
Cash From Investing Activities	-$3.848M	$0.00
Cash From Financing Activities	-$4.801M	$74.29M
Net Change In Cash	-$12.13M	$71.70M
YoY Change	-116.92%	-7178.38%
FREE CASH FLOW
Cash From Operating Activities	-$3.485M	-$2.586M
Capital Expenditures	$16.00K	$0.00
Free Cash Flow	-$3.501M	-$2.586M
YoY Change	35.38%	27.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	7000	USD
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34423497
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35333450
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34423497
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35325801
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35005640
CY2022Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	USD
CY2022Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	USD
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100242000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	112346000	USD
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1338000	USD
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	USD
CY2022Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	3320000	USD
CY2021Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	1528000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	880000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1182000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	105780000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	115056000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	835000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	884000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1090000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1141000	USD
CY2022Q1	us-gaap	Long Term Investments LongTermInvestments	17564000	USD
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	15422000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	437000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	438000	USD
CY2022Q1	us-gaap	Assets Assets	125706000	USD
CY2021Q4	us-gaap	Assets Assets	132941000	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2582000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3038000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	356000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	356000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1232000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-88000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	29000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1144000	USD
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	-0	USD
CY2021Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	37444000	USD
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1864000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-47740000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.49
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34506597
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19146270
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	127118000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1864000	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	918000	USD
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4723000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	50000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	121499000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-66412000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-10296000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	675000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1106000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	82000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	84251000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1864000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-10296000	USD
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-0	USD
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-16885000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	918000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	675000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	150000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	65000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	64000	USD
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-241000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	30000	USD
CY2022Q1	kmph	Fair Value Adjustment Of Investments FairValueAdjustmentOfInvestments	352000	USD
CY2021Q1	kmph	Fair Value Adjustment Of Investments FairValueAdjustmentOfInvestments	0	USD
CY2022Q1	kmph	Consulting Fees Paid In Stock ConsultingFeesPaidInStock	50000	USD
CY2021Q1	kmph	Consulting Fees Paid In Stock ConsultingFeesPaidInStock	82000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	1792000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	8729000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-303000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-273000	USD
CY2022Q1	kmph	Increase Decrease In Operating Lease Rightofuse Asset IncreaseDecreaseInOperatingLeaseRightofuseAsset	-51000	USD
CY2021Q1	kmph	Increase Decrease In Operating Lease Rightofuse Asset IncreaseDecreaseInOperatingLeaseRightofuseAsset	-56000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-418000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1820000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	836000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2945000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4230000	USD
CY2022Q1	kmph	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	89000	USD
CY2021Q4	kmph	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	330000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	31000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	4207000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	5823000	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	3000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	4000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	397925000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	396957000	USD
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	7536000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	2814000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-268893000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-267029000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	121499000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	127118000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	125706000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	132941000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3965000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	12117000	USD
CY2022Q1	kmph	Royalty And Direct Contract Acquisition Costs RoyaltyAndDirectContractAcquisitionCosts	8000	USD
CY2021Q1	kmph	Royalty And Direct Contract Acquisition Costs RoyaltyAndDirectContractAcquisitionCosts	1000000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3082000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2265000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2734000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1892000	USD
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	5824000	USD
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	5157000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1859000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	6960000	USD
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-16885000	USD
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	-0	USD
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	150000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	5000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	199000	USD
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-241000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	30000	USD
CY2022Q1	kmph	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	-245000	USD
CY2021Q1	kmph	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	8000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17256000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1868000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10296000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1864000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-10296000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-78000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-821000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	122000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3485000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2586000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16000	USD
CY2022Q1	us-gaap	Lease Cost LeaseCost	148000	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"/> <p style="margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><i><b>Use of Estimates</b></i></p> <p style="margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition, the useful lives of property and equipment, the recoverability of long-lived assets, the incremental borrowing rate for leases, and assumptions used for purposes of determining stock-based compensation, income taxes, the fair value of long-term investments and the fair value of the derivative and warrant liability, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</p>
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	0	USD
CY2019Q4	kmph	Debt Instrument Convertible Minimum Conversion Price DebtInstrumentConvertibleMinimumConversionPrice	9.328
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	1777437
CY2021Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35333450
CY2021Q1	us-gaap	Lease Cost LeaseCost	190000	USD
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	1000	USD
CY2021Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	4000	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	10000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	61000	USD
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35325801
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34423497
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35005640
CY2022Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	12636639
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	11236414
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35005640
CY2022Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	7649
CY2022Q1	kmph	Stock Repurchase Program Common Stock Repurchased Total StockRepurchaseProgramCommonStockRepurchasedTotal	589792	USD
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34423497
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	918000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	675000	USD
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	306000	USD
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	255000	USD
CY2022Q1	kmph	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment	222000	USD
CY2021Q1	kmph	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment	-37000	USD
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	84000	USD
CY2021Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	292000	USD
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6439369
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9899562
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1864000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-10296000	USD
CY2022Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	-0	USD
CY2021Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	37444000	USD
CY2022Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-1864000	USD
CY2021Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-47740000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34507000
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19146000
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.49
CY2022Q1	kmph	Lessee Lease Option To Extend Maximum Term LesseeLeaseOptionToExtendMaximumTerm	P5Y
CY2022Q1	kmph	Lessee Lease Option To Terminate Term LesseeLeaseOptionToTerminateTerm	P1Y
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	32000	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	32000	USD
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1000	USD
CY2021Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	4000	USD
CY2022Q1	kmph	Finance Lease Cost Total FinanceLeaseCostTotal	33000	USD
CY2021Q1	kmph	Finance Lease Cost Total FinanceLeaseCostTotal	36000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	91000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	91000	USD
CY2022Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	50000	USD
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	50000	USD
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	13000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	13000	USD
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	39000	USD
CY2021Q1	us-gaap	Sublease Income SubleaseIncome	-0	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	11000	USD
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	21000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1090000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1141000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1500000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1588000	USD
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.143	pure
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.120	pure
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.075	pure
CY2022Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	5000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	346000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	6000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	472000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	0	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	484000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	390000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	30000	USD
CY2022Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	11000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1722000	USD
CY2022Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	-0	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	222000	USD
CY2022Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	11000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1500000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	USD
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	3832000	USD
CY2021Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	-0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3848000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2022Q1	kmph	Proceeds From Underwritten Public Offering Net ProceedsFromUnderwrittenPublicOfferingNet	0	USD
CY2021Q1	kmph	Proceeds From Underwritten Public Offering Net ProceedsFromUnderwrittenPublicOfferingNet	49285000	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4723000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	USD
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	68000	USD
CY2021Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1106000	USD
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	10000	USD
CY2021Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	61000	USD
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2881000	USD
CY2022Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-0	USD
CY2021Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	37924000	USD
CY2022Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	25593000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4801000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	74290000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12134000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	71704000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	112346000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4322000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	100212000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	76026000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	5000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	199000	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4000	USD
CY2022Q1	kmph	Deferred Offering Costs Included In Accounts Payable And Accrued Expense DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense	0	USD
CY2021Q1	kmph	Deferred Offering Costs Included In Accounts Payable And Accrued Expense DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpense	17000	USD
CY2022Q1	kmph	Warrants Issued WarrantsIssued	0	USD
CY2021Q1	kmph	Warrants Issued WarrantsIssued	3485000	USD
CY2021Q3	kmph	Sale Of Stock Authorized Amount SaleOfStockAuthorizedAmount	350000000.0	USD
CY2021Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	117000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	114000	USD
CY2021Q1	us-gaap	Variable Lease Payment VariableLeasePayment	13000	USD
CY2022Q1	us-gaap	Short Term Lease Payments ShortTermLeasePayments	50000	USD
CY2021Q1	us-gaap	Short Term Lease Payments ShortTermLeasePayments	50000	USD
CY2022Q1	us-gaap	Variable Lease Payment VariableLeasePayment	13000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD

Files In Submission

Name	View Source	Status
0001437749-22-012182-index-headers.html	Edgar Link	pending
0001437749-22-012182-index.html	Edgar Link	pending
0001437749-22-012182.txt	Edgar Link	pending
0001437749-22-012182-xbrl.zip	Edgar Link	pending
ex_355934.htm	Edgar Link	pending
ex_355935.htm	Edgar Link	pending
ex_355936.htm	Edgar Link	pending
ex_355937.htm	Edgar Link	pending
ex_367377.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
kmph-20220331.xsd	Edgar Link	pending
kmph-20220331_cal.xml	Edgar Link	unprocessable
kmph-20220331_def.xml	Edgar Link	unprocessable
kmph-20220331_lab.xml	Edgar Link	unprocessable
kmph-20220331_pre.xml	Edgar Link	unprocessable
kmph20220331_10q.htm	Edgar Link	pending
kmph20220331_10q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra

2022 Q1 Form 10-Q Financial Statement

#000143774922012182 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZVRA ZEVRA THERAPEUTICS, INC. Stock $zvra

2022 Q1 Form 10-Q Financial Statement

#000143774922012182 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra